Psychiatric Drugs In Children And Adolescents

This book offers a comprehensive survey of the current state of knowledge in the field of neuro-psychopharmacology in childhood and adolescence. In the first part, the essentials of neuro-psychopharmacology are presented in order to provide a deeper understanding of the principles and particularities in the pharmacotherapy of children and adolescents. This part includes information on neurotransmitters and signal transduction pathways, molecular brain structures as targets for psychiatric drugs, characteristics of psychopharmacological therapy in children and adolescents, ontogenetic influences on pharmacokinetics and pharmacodynamics, and pharmacotherapy in the outpatient setting. The part on classes of psychiatric medications, which covers antidepressants, antipsychotics, anxiolytics and sedative-hypnotics, mood stabilizers, and psychostimulants and other drugs used in the treatment of attention-deficit/hyperactivity disorder, provides sufficient background material to better understand how psychoactive drugs work, and why, when, and for whom they should be used. For each drug within a class, information on its mechanisms of action, clinical pharmacology, indications, dosages, and cognate issues are reviewed. In the third part, the disorder-specific and symptom-oriented medication is described and discerningly evaluated from a practical point of view, providing physicians with precise instructions on how to proceed. Psychiatric Drugs in Children and Adolescents includes numerous tables, figures and illustrations and offers a valuable reference work for child and adolescent psychiatrists and psychotherapists, pediatricians, general practitioners, psychologists, and nursing staff, as well as teachers.

New in this edition:¿ Drugs for ADHD thoroughly revised and updated¿ Antipsychotics with many changes and additions, including fully revised lab tests/monitoring¿ Antidepressants fully revised, including new sections on irreversible MAO-B inhibitor and serotonin modulator and stimulator (SMS), revised frequency of adverse effects table and switching strategies recommendations¿ Hypnotics completely revised¿ Mood stabilizers fully revised and a new toxicity comparison table added¿ Drugs of abuse and treatment of substance use disorder comprehensively revised¿ New unapproved treatments with significant updates, including: anti-inflammatories and NMDA agents in anxiety/OCD, cannabis use, and irritability of autism¿ New agents include: brexpiprazole, cariprazine, hypnotic suvorexant, tasimelteon, vortioxetine¿ New formulations and trade names include: Adasuve, Alprazolam Intensol, Aptensio XR, Aristada, Belbuca, Belsomra, Brintellix, Bunavail, Cotempla XR-ODT, Dyanavel XR, Eldepryl, EMSAM, Evekeo, Hemangeol, Hetlioz, Innopran XL, Invega Trinza, Khedezla, Metadol-D, Mydayis, NyQuil, Quillichew ER, Quillivant XR, Rexulti, Som-Pam, Tegretol (liquid), Trintellix, Versacolz, Vraylar, Vyvanse, Zelapar, ZenzediThe Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.¿ Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions¿) for a quick overview of treatment options¿ Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more - all you need to know for each class of drug¿ Potential interactions and side effects summarized in comparison charts¿ With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek¿ Clearly written patient and caregiver information sheets for download as printable PDF filesThis book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.

Quick and comprehensive information on psychotropic drugs for children and adolescents. Accurate and up-to-date Specific to children and adolescents Charts and tables help decision-making Icons and full color More about this book The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choices about psychotropic medications for younger patients. The fifth edition of this widely acclaimed reference has been fully updated and expanded. Updated information on psychiatric disorders in children and adolescents Unique comparison charts (dosages, side effects, pharmacokinetics, interactions...) that allow you to see at a glance which medication is the most suitable for each patient Instantly recognizable icons in full color throughout, allowing you to quickly find all the information you seek: – General information on medications, availability, and indications – Drug action, dosing, pharmacokinetics, and related areas – Warnings and precautions – Patient-related information, such as lab monitoring recommendations, nursing implications, and patient advice Clearly written patient and caregiver information sheets as printable pdf files This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs. New in this edition: New chapters on Prescribing Safely and Ethically to Children and Adolescents, Pharmacogenetic Information for Common Psychotropic Drugs, and Aggression Management in Children and Adolescents Neuroscience-based nomenclature added to Product Availability tables Antipsychotic-Induced Extrapyramidal Side Effect (EPSE) chapter completely revised, plus new section on monitoring scales for EPSE Anxiolytics section on buspirone and benzodiazepine comparison table revised

information. This book aims to do this for practitioners, professionals in health, welfare, and education, and interested laypersons, including parents. This is no easy task, since the levels of technical knowledge vary from that of the special education teacher seeking information about the drugs that many such pupils will be receiving, to that of the modern young child and adolescent psychiatrist whose grasp of the difficult fields of pharmacokinetics (how drugs are absorbed, distributed, and eliminated) and neurotransmitter physiology (via which most psychoactive drugs work) is daunting to the editors, who grew up in the bucolic clinical-empirical era. Inevitably there are sections of the book that will prove too technical for any except the medically qualified, but considerable effort has been applied to make much of the text, especially that discussing the clinical uses and side effects of the drugs, comprehensible to anyone used to getting information by reading. We also take comfort in the fact that many of the major contributions in pediatric psychophar macology have been made by nonmedical professionals, notably psychologists, suggesting that an audience beyond the medically qualified is practicable. One other problem confronted us-whether to organize the book by psycho pathological symptoms (e.g., hyperactivity) and disorders (e.g., autism) or by drugs.

This book is designed to fill a need for a comprehensive but compact and easy-to-use reference for all mental health professionals dealing with children and adolescents. The new edition of the widely praised handbook summarizes the latest information from the published literature (scientific data, controlled clinical trials, case reports) and clinical experience in compact and easy-to-use charts and bulleted lists for each class of psychotropic drug used in children and adolescents. The spiralbound handbook includes for each class of drugs both monograph statements on use in children and adolescents and approved indications, as well as the available data concerning off-label indications, findings from open and double-blind studies concerning doses, adverse affects, and other considerations in these age groups. For each class of drug, summary information is provided on:

"When a child is struggling with an emotional or behavioral problem, parents face many difficult decisions. Is medication the right choice? What about side effects? How long will medication be needed? In this authoritative guide, leading child psychiatrists Drs. Timothy Wilens and Paul Hammerness explain the nuts and bolts of psychiatric medications--from how they work and potential risks to their impact on a child's emotions, school performance, personality, and health. Extensively revised to include the latest information about medications and their uses, the fourth edition is even more accessible, and includes pullouts, bulleted lists, and "take home points" highlighting critical facts. In addition to parents, this is an ideal reference for teachers and other school professionals"--

Research has shown that a range of adult psychiatric disorders and mental health problems originate at an early age, yet the psychiatric symptoms of an increasing number of children and adolescents are going unrecognized and untreated—there are simply not enough child psychiatric providers to meet this steadily rising demand. It is vital that advanced practice registered nurses (APRNs) and primary care practitioners take active roles in assessing behavioral health presentations and work collaboratively with families and other healthcare professionals to ensure that all children and adolescents receive appropriate treatment. Child and Adolescent Behavioral Health helps APRNs address the mental health needs of this vulnerable population, providing practical guidance on assessment guidelines, intervention and treatment strategies, indications for consultation, collaboration, referral, and more. Now in its second edition, this comprehensive and timely resource has been fully updated to include DSM-5 criteria and the latest guidance on assessing, diagnosing, and treating the most common behavioral health issues facing young people. New and expanded chapters cover topics including eating disorders, bullying and victimization, LGBTQ identity issues, and conducting research with high-risk children and adolescents. Edited and written by a team of accomplished child psychiatric and primary care practitioners, this authoritative volume: Provides state-of-the-art knowledge about specific psychiatric and behavioral health issues in multiple care settings Reviews the clinical manifestation and etiology of behavioral disorders, risk and management issues, and implications for practice, research, and education Offers approaches for interviewing children and adolescents, and strategies for integrating physical and psychiatric screening Discusses special topics such as legal and ethical issues, cultural influences, the needs of immigrant children, and child and adolescent mental health policy Features a new companion website containing clinical case studies to apply concepts from the chapters Designed to specifically address the issues faced by APRNs, Child and Adolescent Behavioral Health is essential reading for nurse practitioners and clinical nurse specialists, particularly those working in family, pediatric, community health, psychiatric, and mental health settings.

Presents a user-friendly step-by-step manual on the psychotropic drugs prescribed for children and adolescents by clinicians and nurse practitioners.